Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Total 13F shares
-
638,030
-
Share change
-
-274
-
Total reported value
-
$59,014,644
-
Price per share
-
$92.49
-
Number of holders
-
93
-
Value change
-
+$125,900
-
Number of buys
-
27
-
Number of sells
-
29
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q3 2025
As of 30 Sep 2025,
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
638,030 shares.
The largest 10 holders included
Peak Asset Management, LLC, LPL Financial LLC, UBS Group AG, MORGAN STANLEY, ROYAL BANK OF CANADA, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, Joseph Group Capital Management, MGB Wealth Management, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
93
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.